xarelto
bayer ag - rivaroksabaan - arthroplasty, replacement; venous thromboembolism - antitrombootilised ained - xarelto, co-manustada atsetüülsalitsüülhape (asa) üksi või koos asa pluss clopidogrel või ticlopidine, on näidustatud ennetamine atherothrombotic sündmuste täiskasvanud patsientidel pärast äge koronaarsündroom (acs) kõrgenenud südame biomarkerite. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. täiskasvanud patsientidel, kellele tehti plaaniline puusa- või põlveliigese asendamise operatsiooni venoosse trombemboolia (vte) ennetamine. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
ibandronic acid liconsa 150 mg õhukese polümeerikattega tablett
laboratorios liconsa s.a. - ibandroonhape - õhukese polümeerikattega tablett - 150mg 3tk; 150mg 1tk
alendronic acid/colecalciferol zentiva tablett
zentiva k.s. - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 12tk; 70mg+5600rÜ 2tk
alendronic acid/colecalciferol mylan tablett
mylan pharmaceuticals limited - alendroonhape+kolekaltsiferool - tablett - 70mg+2800rÜ 12tk; 70mg+2800rÜ 4tk
alendronic acid/colecalciferol teva tablett
teva pharma b.v. - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 16tk; 70mg+5600rÜ 12tk; 70mg+5600rÜ 24tk; 70mg+5600rÜ 4tk; 70mg+5600rÜ 28tk
alendronic acid/ colecalciferol sandoz tablett
sandoz pharmaceuticals d.d. - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 4tk; 70mg+5600rÜ 6tk; 70mg+5600rÜ 2tk; 70mg+5600rÜ 12tk
alendronic acid/colecalciferol zentiva tablett
zentiva k.s. - alendroonhape+kolekaltsiferool - tablett - 70mg+2800rÜ 4tk; 70mg+2800rÜ 12tk
alendronic acid/colecalciferol mylan tablett
mylan pharmaceuticals limited - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 12tk
zoledronic acid fresenius kabi 4mg/5ml infusioonilahuse kontsentraat
fresenius kabi polska sp. z o.o. - zoledroonhape - infusioonilahuse kontsentraat - 4mg 5ml 5ml 1tk; 4mg 5ml 5ml 10tk; 4mg 5ml 5ml 4tk
tranexamic acid baxter süste-/infusioonilahus
baxter holding b.v. - traneksaamhape - süste-/infusioonilahus - 100mg 1ml 10ml 10tk; 100mg 1ml 5ml 10tk; 100mg 1ml 5ml 5tk; 100mg 1ml 10ml 5tk